Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117737014B reveals enzyme mutant for Compound I synthesis. Offers high purity and cost reduction in pharmaceutical intermediates manufacturing.
Novel dual enzyme method reduces reaction time and cost for high-purity L-tert-leucine production ensuring reliable supply chain for API intermediate manufacturing processes.
Patent CN106978368A reveals enzymatic route for L-glufosinate precursor. Offers high purity, reduced corrosion, and scalable agrochemical intermediate manufacturing solutions.
Patent CN113481175B discloses OYE2p mutants for stereoselective citral reduction. Discover cost-effective biocatalysis solutions for flavor and fragrance intermediates.
Patent CN104673733B reveals a novel HHDH enzyme route for high-purity statin intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN103122355A details a thermostable ketoreductase enabling high-purity chiral alcohol manufacturing with significant cost reduction and supply chain reliability.
Patent CN117165543A reveals a high-yield biocatalytic route for furfuryl alcohol. Discover cost-effective manufacturing and supply chain advantages for fine chemical intermediates.
Patent CN108587991A reveals novel aminotransferase and isomerase pairs for L-allo-Ile production. Discover green enzymatic methods for high-purity pharmaceutical intermediates and cost reduction.
Patent CN115948360A details an imine reductase mutant achieving >99.5% conversion and 99.6% ee for nicotine analog intermediates, offering significant cost and supply chain advantages.
Patent CN104630125B reveals engineered E. coli for high-purity statin intermediate synthesis with mild conditions and reduced processing complexity.
Patent CN101547893B reveals a novel salt recovery method for biphenylalanine, enabling cost reduction in pharmaceutical intermediate manufacturing through direct extraction and recycling.
Patent CN107488639A reveals a novel toluene monooxygenase for high-purity chiral sulfoxide production. Discover green biocatalytic advantages for pharmaceutical supply chains.
Patent CN112175919B discloses engineered enzymes for efficient D-pantoic acid production, offering cost reduction and supply reliability for vitamin manufacturers.
Novel biocatalytic method for R-mandelic acid production. High purity over 99 percent, cost-effective, scalable process for pharmaceutical supply chains.
Novel enzymatic route for Sitagliptin key intermediate reduces costs and eliminates heavy metals. Ideal for reliable pharmaceutical intermediate suppliers seeking scalable API manufacturing solutions.
Patent CN1100144A details enzymatic resolution for high-purity taxane intermediates, offering cost-effective and scalable pharmaceutical manufacturing solutions.
Patent CN106520890B reveals a novel two-phase fermentation method using Aspergillus ochraceus for efficient steroid dehydrogenation, offering significant cost reduction in API manufacturing.
Patent CN116640737A reveals novel BsER mutants for asymmetric reduction. Enables cost reduction in API manufacturing with high stereoselectivity and supply reliability.
Patent CN116640737A reveals novel BsER mutants for chiral ketone reduction. Enables high-purity pharmaceutical intermediates with reduced manufacturing costs and enhanced supply reliability.
Novel enzymatic route for S-indoline-2-carboxylic acid ensures >99% ee purity and simplified processing for reliable pharmaceutical intermediate supply chains.